Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Danaher_Corporation
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:CEO |
gptkb:Kevin_Ballinger
|
| gptkbp:foundedIn |
1998
|
| gptkbp:founder |
gptkb:John_Ballantyne
gptkb:Michael_Chambers |
| gptkbp:headquartersLocation |
gptkb:Fargo,_North_Dakota,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aldevron
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableFor |
supporting COVID-19 vaccine development
|
| gptkbp:numberOfEmployees |
over 600
|
| gptkbp:operates |
gptkb:Germany
gptkb:Madison,_Wisconsin gptkb:Fargo,_North_Dakota |
| gptkbp:parentCompany |
gptkb:Danaher_Corporation
|
| gptkbp:product |
gptkb:gene
enzymes proteins plasmid DNA |
| gptkbp:servesIndustry |
vaccine development
gene therapy |
| gptkbp:specializesIn |
mRNA production
plasmid DNA production protein production |
| gptkbp:targetUser |
academic researchers
pharmaceutical companies biotech companies |
| gptkbp:website |
https://www.aldevron.com/
|
| gptkbp:bfsParent |
gptkb:Ginkgo_Bioworks
|
| gptkbp:bfsLayer |
5
|